PharmaCorp Announces Agreement to Acquire a Pharmacy
PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is excited to share that it has reached an agreement to acquire a 90% stake in a pharmacy situated in Western Canada from two independent vendors. The total purchase price for this 90% interest is $2,207,170, which will be financed using cash resources. This acquisition is a pivotal move in PharmaCorp's growth strategy.
Details of the Acquisition
Notably, the Vendors will keep a 10% stake in the pharmacy and have committed to remaining involved in its operations. One of the Vendors is expected to sign a long-term employment contract as the managing pharmacist. This arrangement is crucial for ensuring leadership continuity, aligning with PharmaCorp’s primary objective of upholding the highest standards of service and customer satisfaction.
Strategic Importance of the Acquisition
This acquisition marks PharmaCorp’s second significant venture, following the successful completion of its Qualifying Transaction earlier this year. It not only strengthens PharmaCorp’s position in the pharmacy sector but also opens doors for future growth. With the earlier acquisition of a 75% interest in a pharmacy in Saskatoon, PharmaCorp is well-positioned to enhance its operational capabilities across various locations.
Company Vision and Growth Strategy
“We are thrilled about acquiring the pharmacy, which clearly showcases our commitment to providing value to our shareholders through strategic acquisitions,” remarked Al Simpson, Executive Chairperson of PharmaCorp. The decision to retain one of the Vendors in a management role underscores the company’s commitment to maintaining the exceptional service standards that customers expect.
Future Expansion Plans
With the addition of the new pharmacy, PharmaCorp will operate two pharmacies and is determined to continue acquiring independently owned and branded PharmaChoice pharmacies. This ongoing strategy aims to bolster the company’s market presence while ensuring that all acquired pharmacies function under the PharmaChoice brand. As part of its growth plans, PharmaCorp is focused on identifying additional acquisition opportunities throughout Canada.
About PharmaCorp Rx Inc.
As a Capital Pool Company, PharmaCorp successfully completed its qualifying transaction as outlined in Policy 2.4 of the TSX Venture Exchange. This transaction included a strategic partnership with PharmaChoice Canada Inc. and the acquisition of a 75% interest in a pharmacy located in Saskatoon. With a solid expansion strategy in place, PharmaCorp is committed to growing its portfolio and enhancing its operational capabilities within the pharmacy industry.
Contact Information
For more information, please reach out to:
Mr. Alan Simpson
Suite #203, 303 Wellman Lane, Saskatoon, SK S7T 0J1
Tel: (306) 536-3771
Frequently Asked Questions
What is PharmaCorp's latest acquisition?
PharmaCorp has agreed to acquire a 90% interest in a pharmacy located in Western Canada.
How much did PharmaCorp pay for the pharmacy?
The total purchase price for the 90% interest in the pharmacy is $2,207,170.
What role will the Vendors play after the acquisition?
The Vendors will retain a 10% interest in the pharmacy, and one will continue as the managing pharmacist under a long-term employment agreement.
What other acquisitions has PharmaCorp made recently?
Before this acquisition, PharmaCorp acquired a 75% interest in a pharmacy in Saskatoon as part of its qualifying transaction.
What is PharmaCorp’s growth strategy moving forward?
PharmaCorp intends to continue acquiring independently owned and branded PharmaChoice pharmacies to enhance its market presence.
